(Q43833305)

27 November 2017

title

Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. (English)

1 reference

27 November 2017

1 reference

3

1 reference

27 November 2017

Kjell Alving

4

0 references

John Pernow

object named as

John Pernow

series ordinal

5

0 references

author name string

Felix Böhm

series ordinal

1

1 reference

27 November 2017

Bo Lennart Johansson

series ordinal

2

1 reference

27 November 2017

publication date

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

160

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

215-222

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Cloning and expression of a cDNA encoding an endothelin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Potent vasoconstrictor effects and clearance of endothelin in the human forearm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Contribution of endogenous generation of endothelin-1 to basal vascular tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Vasodilator Effects of Endothelin-Converting Enzyme Inhibition and Endothelin ET A Receptor Blockade in Chronic Heart Failure Patients Treated With ACE Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Pathophysiology of endothelin in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Endothelin is a potent mitogen for rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Endothelin-1 Stimulates Monocytes in vitro to Release Chemotactic Activity Identified as Interleukin-8 and Monocyte Chemotactic Protein-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Monoclonal antibodies against human endothelin-converting enzyme-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Inhibition of biological actions of big endothelin-1 by phosphoramidon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Enhanced vasoconstrictor response to endothelin-B-receptor stimulation in patients with atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Human chymase, an enzyme forming novel bioactive 31-amino acid length endothelins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Novel 31-amino-acid-length endothelins cause constriction of vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Atherosclerosis in the human brachial artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900564-0

10.1016/S0021-9150(01)00564-0

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference